Data / Form D filings / X2 Biosystems, Inc.
X2 Biosystems, Inc.: Form D filings
X2 Biosystems, Inc., a biotechnology company in Seattle, WA, filed 13 Form D notices with the SEC between 2010 and 2015. The latest, on April 16, 2015, reports $350,000 sold of a $350,000 offering to 3 investors.
Find out what X2 Biosystems, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1927 POST ALLEY, SUITE 200, Seattle, WA, 98101
- Phone
- (206) 351-0004
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Washington
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1495809
The full lists. Form D filings in Washington: 1,095 rows, $54.75, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 16, 2015 | New notice | $350,000 | $350,000 | $0 | 3 | Mar 2, 2015 | sec.gov |
| Nov 20, 2014 | Amendment | $9,000,000 | $4,220,000 | $4,780,000 | 41 | Apr 7, 2014 | sec.gov |
| Apr 18, 2014 | New notice | $9,000,000 | $2,510,000 | $6,490,000 | 17 | Apr 7, 2014 | sec.gov |
| Dec 19, 2013 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Jul 12, 2013 | New notice | $800,000 | $720,000 | $80,000 | 8 | Jul 3, 2013 | sec.gov |
| Jun 19, 2013 | Amendment | $12,500,000 | $3,273,021 | $9,226,979 | 18 | Jul 20, 2012 | sec.gov |
| Feb 13, 2013 | Amendment | $2,500,000 | $2,115,981 | $384,019 | 18 | Jul 20, 2012 | sec.gov |
| Aug 17, 2012 | New notice | $2,500,000 | $375,000 | $2,125,000 | 2 | Jul 20, 2012 | sec.gov |
| Sep 13, 2011 | New notice | $3,500,000 | $350,000 | $3,150,000 | 5 | Aug 1, 2011 | sec.gov |
| May 17, 2011 | Amendment | $2,200,000 | $1,970,000 | $230,000 | 30 | May 17, 2010 | sec.gov |
| Jan 5, 2011 | Amendment | $1,500,000 | $1,105,000 | $395,000 | 12 | May 17, 2010 | sec.gov |
| Jan 4, 2011 | Amendment | $1,500,000 | $1,105,000 | $395,000 | 12 | May 17, 2010 | sec.gov |
| Jul 2, 2010 | New notice | $1,000,000 | $200,000 | $800,000 | 3 | May 17, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Ralston | Executive Officer, Director |
Other biotechnology companies in Washington that filed recently
- Key Proteo, Inc. $2.3 million · Oct 23, 2026
- Inmedix, Inc. $4 million · Oct 22, 2026
- Q-Immune, Inc. $25,000 · Sep 28, 2026
- Hexamer Therapeutics, Inc $500,000 · Sep 15, 2026
- MalarVx, Inc. $125,000 · Aug 25, 2026
- Strella Biotechnology, Inc. $1.8 million · Aug 14, 2026
Every Form D from the week of Apr 13, 2015 · All recent filings in Washington · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what X2 Biosystems, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.